Evidence map›Paper›PMID 32954274›Full record

ArticleBrain communications2019

Two distinct prions in fatal familial insomnia and its sporadic form.

Atsuko Takeuchi, Shirou Mohri, Hideaki Kai, Akira Tamaoka, Atsushi Kobayashi, Hidehiro Mizusawa, Yasushi Iwasaki, Mari Yoshida, Hiroshi Shimizu, Shigeo Murayama and 4 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Brain communications, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Defining the Prion Type of Fatal Familial Insomnia.Pathogens (Basel, Switzerland) · 2021
    Article
  6. Potential for transmission of sporadic Creutzfeldt-Jakob disease through peripheral routes.Laboratory investigation; a journal of technical methods and pathology · 2021
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 2 countries.

Atsuko TakeuchiDepartment of Neurological Science, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan.ORCID 0000-0001-5582-737X
Shirou MohriDepartment of Neurological Science, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan.
Hideaki KaiDepartment of Neurological Science, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan.
Akira TamaokaDepartment of Neurology, Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki 305-8576, Japan.
Atsushi KobayashiLaboratory of Comparative Pathology, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo 060-0818, Japan.
Hidehiro MizusawaThe National Center Hospital, National Center of Neurology and Psychiatry, Tokyo 102-0076, Japan.
Yasushi IwasakiDepartment of Neuropathology, Institute for Medical Science of Aging, Aichi Medical University, Nagakute, Aichi 480-1195, Japan.
Mari YoshidaDepartment of Neuropathology, Institute for Medical Science of Aging, Aichi Medical University, Nagakute, Aichi 480-1195, Japan.
Hiroshi ShimizuDepartment of Pathology, Brain Research Institute, University of Niigata, Niigata 951-8585, Japan.
Shigeo MurayamaDepartment of Neurology and Neuropathology (The Brain Bank for Aging Research), Tokyo 173-0015, Japan.
Shigetoshi KurodaZikei Hospital, Okayama 702-8508, Japan.
Masanori MoritaResearch and Development Division, Japan Blood Products Organization, Kobe 650-0047, Japan.
Piero ParchiDepartment of Experimental, Diagnostic and Specialty Medicine (DIMES), University of Bologna, Bologna 40126, Italy.ORCID 0000-0002-9444-9524
Tetsuyuki KitamotoDepartment of Neurological Science, Tohoku University Graduate School of Medicine, Sendai 980-8575, Japan.
Tohoku University · JPAichi Medical University · JPHokkaido University · JPIstituto delle Scienze Neurologiche di Bologna · ITNational Center of Neurology and Psychiatry · JPNiigata University · JPUniversity of Tsukuba · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fatal familial insomnia is a genetic prion disease, which is associated with the aspartic acid to asparagine substitution at codon 178 of the prion protein gene. Although the hallmark pathological feature is thalamic and olivary degeneration, there is a patient with an atypical fatal familial insomnia without the hallmark feature. The cause of the pathological variability is unclear. We analysed a Japanese fatal familial insomnia kindred and compared one atypical clinicopathological fatal familial insomnia phenotype case and typical fatal familial insomnia phenotype cases with transmission studies using multiple lines of knock-in mice and with protein misfolding cyclic amplification. We also analysed the transmissibility and the amplification properties of sporadic fatal insomnia. Transmission studies revealed that the typical fatal familial insomnia with thalamic and olivary degeneration showed successful transmission only using knock-in mice expressing human-mouse chimeric prion protein gene. The atypical fatal familial insomnia with spongiform changes showed successful transmission only using knock-in mice expressing bank vole prion protein gene. Two sporadic fatal insomnia cases with thalamic and olivary degeneration showed the same transmissibility as the typical fatal familial insomnia phenotype. Interestingly, one sporadic fatal insomnia case with thalamic/olivary degeneration and spongiform changes showed transmissibility of both the typical and atypical fatal familial insomnia phenotypes. Protein misfolding cyclic amplification could amplify both typical fatal familial insomnia cases and sporadic fatal insomnia cases but not the atypical fatal familial insomnia phenotype or other sporadic Creutzfeldt-Jakob disease subtypes. In addition to clinical findings and neuropathological features, the transmission properties and the amplification properties were different between the typical and atypical fatal familial insomnia phenotypes. It is suggested that two distinct prions were associated with the diversity in the fatal familial insomnia phenotype, and these two prions could also be detected in sporadic fatal insomnia.

Indexed as

fatal familial insomniaknock-in mouseprotein misfolding cyclic amplificationsporadic fatal insomniatransmission study

Identifiers

PMID32954274
PMCPMC7425372
OpenAlexW2994639966

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.